exosome

IP bolsters Company’s already dominant and broad position with respect to exosome therapeutics Acquisition is in line with long-term strategy to improve exosome-mediated delivery to enable…

<!-- Name:DistributionId Value:8832866 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8787642 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

HAIFA, Israel and CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CVE) (J90:FRA) (the “Company” or “NurExone”), a biopharmaceutical company developing…

HOUSTON, Nov. 28, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database titled "Exosome Therapeutics Market" with 100+ market data…

SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today a strategic…

Proprietary technology generates Exosome Polymer Hybrids (EPHs) which allow for efficient and versatile method of customizing cargoes of Treg-derived exosomes using oligonucleotide tethers…

New research from UT Southwestern suggests that RNA exosomes -- the cellular machines that degrade old molecules of RNA -- play a key role in the development of B cells, which are critical…

Pune, June 13, 2022 (GLOBE NEWSWIRE) -- Exosome Diagnostic and Therapeutic Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service,…

CAMBRIDGE, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of…